Positron Emission Tomography (PET)

Global Positron Emission Tomography (PET) Market to Reach US$2.7 Billion by 2030

The global market for Positron Emission Tomography (PET) estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. PET-CT, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the PET-MRI segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$553.6 Million While China is Forecast to Grow at 8.1% CAGR

The Positron Emission Tomography (PET) market in the U.S. is estimated at US$553.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$591.3 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Positron Emission Tomography (PET) Market - Key Trends and Drivers Summarized

Positron Emission Tomography (PET): Unveiling the Intricacies of Human Physiology

Positron Emission Tomography (PET) is a sophisticated imaging technique that enables the visualization and measurement of metabolic processes in the body. Unlike traditional imaging methods that focus on anatomical structures, PET scans provide functional imaging by detecting the gamma rays emitted indirectly by a positron-emitting radiotracer. Typically, the radiotracer is a biologically active molecule labeled with a radioactive isotope, such as fluorodeoxyglucose (FDG), which accumulates in tissues with high metabolic activity. When the radiotracer decays, it emits positrons that collide with electrons, producing gamma rays that are detected by the PET scanner. This process allows clinicians to generate detailed images of biological functions, offering invaluable insights into the physiology and pathology of diseases.

How Are Technological Advancements Enhancing PET Imaging?

Technological advancements have revolutionized PET imaging, enhancing its accuracy, resolution, and application scope. The integration of PET with computed tomography (CT) or magnetic resonance imaging (MRI) has resulted in hybrid imaging systems like PET/CT and PET/MRI, combining the functional imaging capabilities of PET with the anatomical detail of CT or MRI. This fusion provides a comprehensive diagnostic tool that improves disease localization and characterization. Advances in detector technology, such as the development of digital PET scanners, have significantly improved image resolution and sensitivity, allowing for earlier and more accurate disease detection. Additionally, innovations in radiotracer development have expanded the range of metabolic and molecular processes that can be visualized, enabling PET to investigate various conditions, from cancer and cardiovascular diseases to neurological disorders.

What Are the Key Applications and Benefits of PET Imaging?

PET imaging is widely used in oncology, neurology, cardiology, and infectious disease diagnosis, offering numerous clinical benefits. In oncology, PET is indispensable for detecting, staging, and monitoring the treatment response of various cancers, providing crucial information that guides therapeutic decisions. In neurology, PET scans are used to diagnose and study neurological conditions such as Alzheimer`s disease, epilepsy, and Parkinson`s disease, by revealing abnormalities in brain metabolism. Cardiologists use PET imaging to assess myocardial perfusion and viability, aiding in the diagnosis and management of coronary artery disease. The ability to provide functional imaging makes PET a powerful tool for tracking disease progression and evaluating the efficacy of treatments. Moreover, the non-invasive nature of PET and its ability to provide quantitative data enhance its utility in both clinical practice and research settings.

What Factors Are Driving the Growth in the PET Imaging Market?

The growth in the positron emission tomography (PET) market is driven by several factors. The increasing prevalence of cancer and neurological disorders is a significant driver, as PET imaging is crucial for the accurate diagnosis and management of these conditions. Technological advancements that enhance the resolution, sensitivity, and capabilities of PET scanners are also propelling market growth. The integration of PET with other imaging modalities, such as CT and MRI, has expanded its clinical applications and improved diagnostic accuracy. Additionally, the development of new radiotracers that target specific metabolic pathways and molecular markers is broadening the scope of PET imaging. The rising adoption of PET in clinical research and drug development, coupled with the growing demand for non-invasive diagnostic techniques, is further contributing to market growth. These factors, combined with increasing healthcare expenditure and the expansion of healthcare infrastructure in emerging markets, are driving the sustained growth of the PET imaging market.

SCOPE OF STUDY:

The report analyzes the Positron Emission Tomography (PET) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Full Ring, Partial Ring); Modality (PET-CT, PET-MRI); Application (Oncology, Cardiology, Neurology, Other Applications); End-Use (Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 42 Featured) -

• Advanced Accelerator Applications SA
• Best ABT Molecular Imaging, Inc.
• Curasight A/S
• Digiray Corporation
• DuchemBio, Co., Ltd.
• GE Healthcare
• Hitachi Ltd.
• Neusoft Corporation
• PETsys Electronics SA
• Philips Healthcare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.